Review
Nature Reviews Cancer 7, 281-294 (April 2007) | doi:10.1038/nrc2110
Protein kinase C and other diacylglycerol effectors in cancer
Erin M. Griner1 & Marcelo G. Kazanietz1 About the authors
Abstract
Almost three decades after the discovery of protein kinase C (PKC), we still have only a partial understanding of how this family of serine/threonine kinases is involved in tumour promotion. PKC isozymes — effectors of diacylglycerol (DAG) and the main targets of phorbol-ester tumour promoters — have important roles in cell-cycle regulation, cellular survival, malignant transformation and apoptosis. How do PKC isozymes regulate these diverse cellular processes and what are their contributions to carcinogenesis? Moreover, what is the contribution of all phorbol-ester effectors, which include PKCs and small G-protein regulators? We now face the challenge of dissecting the relative contribution of each DAG signal to cancer progression.
- View At a Glance
Author affiliations
- Department of Pharmacology and Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6160, USA.
Correspondence to: Marcelo G. Kazanietz1 Email: marcelo@spirit.gcrc.upenn.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
T cells: getting a GRP on RasNature Immunology News and Views (01 Oct 2000)
A retrograde step forwardNature News and Views (12 Nov 1992)
RESEARCH
Phospholipase Cγ/diacylglycerol-dependent activation of β2-chimaerin restricts EGF-induced Rac signalingThe EMBO Journal Article (17 May 2006)
Transcriptional activation of c-fos by oncogenic Ha-Ras in mouse mammary epithelial cells requires the combined activities of PKC-λ, ε and ζThe EMBO Journal Article (15 Jul 1998)
See all 65 matches for Research